- Report
- January 2026
- 197 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- March 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 312 Pages
Global
From €4379EUR$5,000USD£3,801GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 511 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 235 Pages
Global
From €2627EUR$2,999USD£2,280GBP
- Report
- September 2025
- 219 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- July 2025
- 260 Pages
Global
From €3722EUR$4,250USD£3,231GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 190 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- November 2025
- 198 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP

The HbA1C Testing market within the Biotechnology industry is a rapidly growing sector. It is used to measure the average amount of glucose in the blood over a period of two to three months. This test is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to detect pre-diabetes and to monitor the risk of developing diabetes.
The HbA1C Testing market is driven by the increasing prevalence of diabetes, the growing awareness of the importance of early diagnosis and treatment, and the availability of advanced testing technologies. The market is also supported by the increasing demand for point-of-care testing and the development of new products.
Some of the major companies in the HbA1C Testing market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Alere, and Bio-Rad Laboratories. Show Less Read more